ID: ALA4683930
Type: Binding
Description: Protac activity at E3 ubiquitin ligase/EGFR in human HCC827 cells assessed as increase in degradation of EGFR at 0.1 uM pretreated with (1-(6-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-ylamino)-2-(4-fluorophenylamino)pyrido[3,4-d]pyrimidin-4-yl)piperidin-4-yl)methanol and incubated for 6 hrs followed by compound addition and measured after 32 hrs by Western blot analysis
Format: BAO_0000219
Organism: Homo sapiens
Cell type: HCC827
Target: Unchecked(ALA612545)
Document: ALA4680163
Protac activity at E3 ubiquitin ligase/EGFR in human HCC827 cells assessed as increase in degradation of EGFR at 0.1 uM pretreated with (1-(6-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-ylamino)-2-(4-fluorophenylamino)pyrido[3,4-d]pyrimidin-4-yl)piperidin-4-yl)methanol and incubated for 6 hrs followed by compound addition and measured after 32 hrs by Western blot analysis: 1
Bioactivity
Activity Types for Assay ALA4683930
Activity
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
913.07 | 6.12 | 6.12 |
1070.35 |